发明名称 |
Imaging probes, methods of making imaging probes, and methods of imaging |
摘要 |
In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, embodiments of the present disclosure, in one aspect, relate to methods of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject or sample, methods of diagnosing the presence of one or more angiogenesis related diseases or related biological events in a subject or sample, method of monitoring the progress of one or more angiogenesis related diseases or related biological events in a subject or sample, a 18F-FBEM-CYS-ZEGFR:1907 probe, compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe, and pharmaceutical compositions including a 18F-FBEM-CYS-ZEGFR:1907 probe and the like. |
申请公布号 |
US8753605(B2) |
申请公布日期 |
2014.06.17 |
申请号 |
US201113199428 |
申请日期 |
2011.08.30 |
申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Cheng Zhen;Gambhir Sanjiv Sam;Miao Zheng;Liu Hongguang;Ren Gang |
分类号 |
A61K51/00;A61M36/14;A61K49/00;A61K38/16;A61K49/14;A61K51/08 |
主分类号 |
A61K51/00 |
代理机构 |
Thomas|Horstemeyer, LLP |
代理人 |
Thomas|Horstemeyer, LLP |
主权项 |
1. A method of detecting the over-expression of epidermal growth factor receptor (EGFR) in a subject, comprising:
administering to the subject a 18F-FBEM-CYS-ZEGFR:1907 probe, wherein 18F-FBEM is N-2-(4-18F-fluorobenzamido)ethyl-maleimide), wherein ZEGFR:1907 is SEQ ID NO: 1, and CYS is cysteine; imaging at least a portion of the subject; and detecting the 18F-FBEM-CYS-ZEGFR:1907 probe, wherein the location of the 18F-FBEM-CYS-ZEGFR:1907 probe corresponds to the over-expression of the EGFR.
|
地址 |
Palo Alto CA US |